Poland· PL-100397744
Exjade
A deferasirox product containing deferasiroxum, registered in Poland by Novartis Europharm Limited. The same ATC class is registered in 18 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Deferasirox is registered in 18 of 19 countries.
Countries holding a registration under ATC V03AC03 (deferasirox), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 10 of them publish a price we can compare per daily dose
Deferasirox · ATC V03AC03
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of deferasirox costs, country by country.
Normalised to the WHO defined daily dose (0.98 g), the median price runs from $27.16 in France to $59.57 in Switzerland — a ×2.2 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Deferasirox · price per daily dose (0.98 g)
USD · FX 28 Sept 2026
- CH Switzerland$59.57
- IT Italy$43.21
- FR France$27.16
The record
At a glance
URPL (Poland)- Active substance
- Deferasiroxum
- Manufacturer
- Novartis Europharm Limited
- Country
- Poland (PL)
- ATC code
- V03AC03
- ATC class
- Deferasirox
- Defined daily dose
- 0.98 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991354411
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
616 interactions on record for deferasirox.
Graded by severity as the source publishes them — 205 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Deferasirox · interactions on record
616 records
- 205 severe
- 399 moderate
- 12 minor
Most severe, free to view
- NeomycinA07AA01severe
- StreptomycinA07AA04severe
- Polymyxin BA07AA05severe
- Amphotericin BA07AA07severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Deferasirox in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesDeferasiroxCipla USA Inc.
- CzechiaEXJADENovartis Europharm Limited, Dublin
- FinlandEXJADENovartis Europharm Limited
- IrelandExjade 180 mg granules in sachetNovartis Europharm Limited
- BelgiumExjade 180 mgNovartis Europharm
- NetherlandsExjade 180 mg, granulesNovartis Europharm Limited
- SwedenEXJADE 180 mg Granulat i dospåseNovartis Europharm Limited
- IcelandExjadeNovartis Europharm Limited*
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Deferasirox G.L., Deferasirox Ratiopharm
- Belgium · Deferasirox Ab, Deferasirox Ab Ab
- Bulgaria · Deferasirox Synthon, Ziadex
- Cyprus · Deferasirox Msn, Issoferrol
- Czechia · Deferasirox Auxpharma, Deferasirox Glenmark
- Germany · Deferasi Puren, Deferasirox Abdi
- Denmark · Deferasirox Deferasirox "jubilant", Deferasirox Glenmark
- Spain · Deferasirox Abdi, Deferasirox Aurovitas
- Finland · Deferasirox Glenmark, Deferasirox Stada
- France · Deferasirox Arrow, Deferasirox Bgr
- United Kingdom (Northern Ireland) · Deferasirox Abdi Farma, Deferasirox Amarox
- Greece · Deferasirox Pharmathen, Deferasirox Rafarm
- Croatia · Deferasiroks Pliva, Deferasiroks Umedica
- Hungary · Deferasirox Msn, Deferasirox Pharmascience
- Iceland · Deferasirox Accord, Deferasirox Medical Valley
- Italy · Deferasirox Abdi, Deferasirox Aurobindo
- Liechtenstein · Deferasirox Accord, Deferasirox Mylan
- Latvia · Deferasirox Umedica
- Malta · Deferasirox Pharos
- Netherlands · Deferasirox Abdi, Deferasirox Amarox
- Norway · Deferasirox Accord, Deferasirox Medical Valley
- Portugal · Deferasirox 180 Mg, Deferasirox 360 Mg
- Romania · Deferasirox Msn Laboratories, Deferasirox Sanexcel
- Sweden · Deferasirox Glenmark, Deferasirox Jubilant
- Slovakia · Deferasirox, Deferasirox Glenmark
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d473d010-aaab-46cb-8c05-1ea181fa1766 GET /v1/drugs/d473d010-aaab-46cb-8c05-1ea181fa1766?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Granulat",
"source": "urpl",
"strength": "180 mg",
"packaging": "05909991354411 ¦ Rpz ¦ EU/1/06/356/021 ¦ 125531\n30 sasz. 180 mg",
"substance": "Deferasiroxum 180 mg",
"common_name": "Deferasiroxum",
"pl_product_id": "100397744",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about deferasirox.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.